Author: Kotze, Maritha J.
Similar Items: Bone health in post-menopausal patients with breast cancer treated with aromatase inhibitors: factors predicting the risk for osteoporosis.
- Investigating the effects of progestins used in contraception and menopausal hormone therapy on aromatase expression and activity
- Assessment of point-of-care testing for prediction of aromatase inhibitor-associated side effects in obese postmenopausal breast cancer patients screened for cardiovascular risk factors
- Osteoporosis in rheumatoid arthritis
- Prospektiewe risikofaktor-analise in pasiente met bewese osteoperose
- In vitro effect of a sirtuin inhibitor and its possible synergistic effect with a potential tubulin inhibitor on breast cancer cell lines
- Characterisation of BRCA1 genomic rearrangements in South African breast and/or ovarian cancer families